A significant proportion of patients with schizophrenia have depressive symptoms [Lindenmayer, J.-P., 1991; Siris S.G., 2000; Majadas, S., 2012; Miura I., 2021; Liu, 2021]. If in the postpsychotic period depression is found in approximately 20% of patients with schizophrenia, then at the time of exacerbations its frequency increases to 60%, and in total in the anamnesis, especially at the initial stage,. When taking into account the anamnestic data, especially the initial stage, the incidence of depression reaches 80% of patients with schizophrenia suffer from depression [Upthegrove, R., 2017]. Depression is now considered part of the main symptomatology of schizophrenia, added as one of the dimensions in the diagnosis of schizophrenia spectrum disorders [Tandon, R., 2013; Upthegrove, R., 2017; Liu, 2021]. As it turned out, neither the traditional dichotomy of affective disorders and schizophrenia, nor their polarization with the "introduction" of an intermediate diagnostic category - schizoaffective psychosis, nor the now prevailing concept of a wide range of intermediate phenotypes with different representations of psychotic and affective disorders, or a multidimensional phenomenological continuum from conditionally " pure" schizophrenia to the same "pure" bipolar disorder [Reininghaus, U., 2016, 2019; Tamminga, C.A., 2013]. It remains problematic to single out a reference or key feature that makes it possible to distinguish related forms of psychotic and affective disorders. For example, symptoms of depression in patients with schizophrenia are associated with cognitive impairment and in real clinical practice, when assessed at the current moment, are difficult to distinguish from typical negative symptoms of schizophrenia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.